By PETER BENESH, INVESTOR’S BUSINESS DAILYPosted 04/29/2009 06:38 PM ET
The good news is, you’re likely to live longer than your ancestors. The bad news: You’ll have longer to cope with the consequences of aging.
One issue is age-related macular degeneration, a condition that in the worst cases can reduce vision to near-blindness. Researchers in Britain, now in partnership with U.S. drug giant Pfizer (PFE), are working on a treatment. And it uses stem cells.
Pete Coffey, a professor at the University College London Institute for Ophthalmology and leader of the London Project to Cure Blindness, hopes to head off controversy over use of embryonic stem cells.